HPV vaccine and adolescent males

Vaccine

Volumn 29, Issue 34, 2011, Pages 5595-5602

  Reiter, Paul L ^a,b   McRee, Annie Laurie ^a   Kadis, Jessica A ^a   Brewer, Noel T ^a,b  

^a The University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Adolescent health; HPV vaccine; Males

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADOPTION; ADULT; ARTICLE; DNA VIRUS INFECTION; DRUG EFFICACY; FEMALE; HEALTH CARE SURVEY; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONHUMAN; PARENT; PRIORITY JOURNAL; UNITED STATES; WART VIRUS;

ADOLESCENT; ADULT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS VACCINES; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; PEER GROUP; QUESTIONNAIRES;

EID: 79960562803     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.06.020     Document Type: Article

References (61)

1. Weinstock H., Berman S., Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004, 36(1):6-10.
2. Dunne E.F., Nielson C.M., Stone K.M., Markowitz L.E., Giuliano A.R. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis 2006, 194(8):1044-1057.
3. Dunne E.F., Nielson C.M., Hagensee M.E., Papenfuss M.R., Harris R.B., Herrel N., et al. HPV 6/11, 16, 18 seroprevalence in men in two US cities. Sex Transm Dis 2009, 36(11):671-674.
4. Lu B., Hagensee M.E., Lee J.H., Wu Y., Stockwell H.G., Nielson C.M., et al. Epidemiologic factors associated with seropositivity to human papillomavirus type 16 and 18 virus-like particles and risk of subsequent infection in men. Cancer Epidemiol Biomarkers Prev 2010, 19(2):511-516.
5. Newall A.T., Brotherton J.M., Quinn H.E., McIntyre P.B., Backhouse J., Gilbert L., et al. Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia. Clin Infect Dis 2008, 46(11):1647-1655.
6. Partridge J.M., Hughes J.P., Feng Q., Winer R.L., Weaver B.A., Xi L.F., et al. Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students. J Infect Dis 2007, 196(8):1128-1136.
7. Brown D.R., Schroeder J.M., Bryan J.T., Stoler M.H., Fife K.H. Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 1999, 37(10):3316-3322.
8. Lacey C.J., Lowndes C.M., Shah K.V. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006, 24(Suppl. 3). S3/35-S3/41.
9. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006;24(Suppl. 3):S3/11-25.
10. Reiter P.L., Pendergraft W.F., Brewer N.T. Meta-analysis of human papillomavirus infection concordance. Cancer Epidemiol Biomarkers Prev 2010, 19(11):2916-2931.
11. Bosch F.X., Castellsague X., Munoz N., de Sanjose S., Ghaffari A.M., Gonzalez L.C., et al. Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst 1996, 88(15):1060-1067.
12. Habel L.A., Van Den Eeden S.K., Sherman K.J., McKnight B., Stergachis A., Daling J.R. Risk factors for incident and recurrent condylomata acuminata among women. A population-based study. Sex Transm Dis 1998, 25(6):285-292.
13. Centers for Disease Control and Prevention (CDC) FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010, 59(20):630-632.
14. Advisory Committee on Immunization Practices. Vaccines for children program - vaccines to prevent human papillomavirus; 2009. Available from: http://www.cdc.gov/vaccines/programs/vfc/downloads/resolutions/1009hpv-508.pdf.
15. Haupt R.M., Sylvester G.C. HPV disease in males and vaccination: Implications and opportunities for pediatricians. Infect Dis Child 2010, Available from:. http://www.pediatricsupersite.com/view.aspx%3Frid=66396.
16. U.S. Food and Drug Administration. Gardasil; 2010. Available from: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094042.htm.
17. U.S. Food and Drug Administration. December 22, 2010 Approval Letter - Gardasil; 2010. Available from: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm238074.htm.
18. Elbasha E.H., Dasbach E.J. Impact of vaccinating boys and men against HPV in the United States. Vaccine 2010, 28(42):6858-6867.
19. Liddon N., Hood J., Wynn B.A., Markowitz L.E. Acceptability of human papillomavirus vaccine for males: a review of the literature. J Adolesc Health 2010, 46(2):113-123.
20. Reiter P.L., McRee A.L., Gottlieb S.L., Brewer N.T. HPV vaccine for adolescent males: acceptability to parents post-vaccine licensure. Vaccine 2010, 28(38):6292-6297.
21. Reiter P.L., Brewer N.T., McRee A.L., Gilbert P., Smith J.S. Acceptability of HPV vaccine among a national sample of gay and bisexual men. Sex Transm Dis 2010, 37(3):197-203.
22. Reiter P.L., Brewer N.T., Smith J.S. Human papillomavirus knowledge and vaccine acceptability among a national sample of heterosexual men. Sex Transm Infect 2010, 86(3):241-246.
23. Allen J.D., Fantasia H.C., Fontenot H., Flaherty S., Santana J. College men's knowledge, attitudes, and beliefs about the human papillomavirus infection and vaccine. J Adolesc Health 2009, 45(5):535-537.
24. McRee A.L., Reiter P.L., Brewer N.T. Vaccinating adolescent girls against human papillomavirus-Who decides?. Prev Med 2010, 50(4):213-214.
25. Middleman A.B., Rosenthal S.L., Rickert V.I., Neinstein L., Fishbein D.B., D'Angelo L., et al. Adolescent immunizations: a position paper of the Society for Adolescent Medicine. J Adolesc Health 2006, 38(3):321-327.
26. Dennis J.M. Knowledge panel design summary 2010, Available from:. http://www.%20knowledgenetworks.%20com/knpanel/docs/KnowledgePanel(R)-Design-Summary-Description.%20pdf.
27. Fazekas K.I, Brewer N.T., Smith J.S. HPV vaccine acceptability in a rural Southern area. J Womens Health (Larchmt) 2008, 17(4):539-548.
28. Keating K.M., Brewer N.T., Gottlieb S.L., Liddon N., Ludema C., Smith J.S. Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer. J Adolesc Health 2008, 43(4 (Suppl.)):S61-S67.
29. Reiter P.L., Brewer N.T., Gottlieb S.L., McRee A.L., Smith J.S. Parents' health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med 2009, 69(3):475-480.
30. Weinstein N.D. The precaution adoption process. Health Psychol 1988, 7(4):355-386.
31. Weinstein N.D., Sandman P.M. A model of the precaution adoption process: evidence from home radon testing. Health Psychol 1992, 11(3):170-180.
32. McRee A.L., Brewer N.T., Reiter P.L., Gottlieb S.L., Smith J.S. The Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS): Scale development and associations with intentions to vaccinate. Sex Transm Dis 2010, 37(4):234-239.
33. Office of Management and Budget. Standards for defining metropolitan and micropolitan statistical areas; notice. Federal Register 65 (249):82227-38.
34. Pew Research Center. Question search. Available from: 2010. Available from: http://people-press.org/.
35. Gottlieb S.L., Brewer N.T., Sternberg M.R., Smith J.S., Ziarnowski K., Liddon N., et al. Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. J Adolesc Health 2009, 45(5):430-437.
36. Caskey R., Lindau S.T., Alexander G.C. Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health 2009, 45(5):453-462.
37. Centers for Disease Control, Prevention (CDC) Vaccination coverage among adolescents aged 13-17 years - United States, 2007. MMWR Morb Mortal Wkly Rep 2008, 57(40):1100-1103.
38. Chao C., Slezak J.M., Coleman K.J., Jacobsen S.J. Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health 2009, 99(6):1137-1142.
39. Centers for Disease Control and Prevention (CDC) National, state, and local area vaccination coverage among adolescents aged 13-17 years - United States, 2009. MMWR Morb Mortal Wkly Rep 2010, 59(32):1018-1023.
40. Brabin L., Roberts S.A., Stretch R., Baxter D., Chambers G., Kitchener H., et al. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ 2008, 336(7652):1056-1058.
41. Brotherton J.M., Deeks S.L., Campbell-Lloyd S., Misrachi A., Passaris I., Peterson K., et al. Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia. Commun Dis Intell 2008, 32(4):457-461.
42. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., Unger E.R., et al. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007, 56(RR-2):1-24.
43. Allen J.D., Mohllajee A.P., Shelton R.C., Othus M.K., Fontenot H.B., Hanna R. Stage of adoption of the human papillomavirus vaccine among college women. Prev Med 2009, 48(5):420-425.
44. Calloway C., Jorgensen C.M., Saraiya M., Tsui J. A content analysis of news coverage of the HPV vaccine by U.S. newspapers. January 2002-June 2005. J Womens Health (Larchmt) 2006, 15(7):803-809.
45. Habel M.A., Liddon N., Stryker J.E. The HPV vaccine: a content analysis of online news stories. J Womens Health (Larchmt) 2009, 18(3):401-407.
46. Kelly B.J., Leader A.E., Mittermaier D.J., Hornik R.C., Cappella J.N. The HPV vaccine and the media: how has the topic been covered and what are the effects on knowledge about the virus and cervical cancer?. Patient Educ Couns 2009, 77(2):308-313.
47. McRee A.L., Reiter P.L., Chantala K., Brewer N.T. Does framing human papillomavirus vaccine as preventing cancer in men increase vaccine acceptability?. Cancer Epidemiol Biomarkers Prev 2010, 19(8):1937-1944.
48. Hopfer S., Clippard J.R. College women's HPV vaccine decision narratives. Qual Health Res 2011, 21(2):262-277.
49. Ziarnowski K.L., Brewer N.T., Weber B. Present choices, future outcomes: anticipated regret and HPV vaccination. Prev Med 2009, 48(5):411-414.
50. Brewer N.T., Fazekas K.I. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 2007, 45(2-3):107-114.
51. Brewer N.T., Gottlieb S.L., Reiter P.L., McRee A.L., Liddon N., Markowitz L., et al. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis 2011, 38(3):197-204.
52. Daley E.M., Vamos C.A., Buhi E.R., Kolar S.K., McDermott R.J., Hernandez N., et al. Influences on human papillomavirus vaccination status among female college students. J Womens Health (Larchmt) 2010, 19(10):1885-1891.
53. Becker M.H. The Health Belief Model and personal health behavior. Health Educ Monogr 1974, 2:324-473.
54. Painter J.E., Sales J.M., Pazol K., Grimes T., Wingood G.M., DiClemente R.J. Development, theoretical framework, and lessons learned from implementation of a school-based influenza vaccination intervention. Health Promot Pract 2010, 11(3 Suppl):42S-52S.
55. Hawe P., McKenzie N., Scurry R. Randomised controlled trial of the use of a modified postal reminder card on the uptake of measles vaccination. Arch Dis Child 1998, 79(2):136-140.
56. Hughes J., Cates J.R., Liddon N., Smith J.S., Gottlieb S.L., Brewer N.T. Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiol Biomarkers Prev 2009, 18(2):363-372.
57. Briss P.A., Rodewald L.E., Hinman A.R., Shefer A.M., Strikas R.A., Bernier R.R., et al. Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med 2000, 18(1 (Suppl.)):97-140.
58. Tierney C.D., Yusuf H., McMahon S.R., Rusinak D., O'Brien M.A., Massoudi M.S., et al. Adoption of reminder and recall messages for immunizations by pediatricians and public health clinics. Pediatrics 2003, 112(5):1076-1082.
59. Chao C., Velicer C., Slezak J.M., Jacobsen S.J. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol 2010, 171(3):357-367.
60. Reiter P.L., Cates J.R., McRee A.L., Gottlieb S.L., Shafer A., Smith J.S., et al. Statewide HPV vaccine initiation among adolescent females in North Carolina. Sex Transm Dis 2010, 37(9):549-556.
61. Baker L.C. Validity of the survey of health and internet and knowledge Network's panel and sampling 2003, Available from:. http://www.knowledgenetworks.com/ganp/docs/Appendix%2520Survey%2520of%2520Health%2520and%2520the%2520Internet.pdf.